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Pseudomonas aeruginosa is one of the causative pathogens of bovine mastitis. 
Most P. aeruginosa strains possess the type III secretion system (TTSS), which may 
increase somatic cell counts (SCCs) in milk from mastitis-affected cows. Moreover, 
most of P. aeruginosa cells can form biofilms, thereby reducing antibiotic efficacy. In 
this study, the presence and effect of TTSS-related genotypes on increase of SCCs 
among 122 P. aeruginosa isolates obtained from raw milk samples from mastitis-
affected cows and their antibiotic susceptibility at planktonic and biofilm status were 
investigated. Based on the presence of TTSS-related genes a total of 82.7% of the iso-
lates were found to harbour exoU and/or exoS genes, including the invasive (exoU–/ 
exoS+, 69.4%), cytotoxic (exoU+/exoS–, 8.3%) and cytotoxic/invasive strains (exoU+/ 
exoS+, 5.0%). Milk containing exoS-positive isolates had higher SCCs than those con-
taining exoS-negative isolates. The majority of isolates showed gentamicin, amikacin, 
meropenem and ciprofloxacin susceptibility at planktonic status. However, the suscep-
tibility was decreased at the biofilm status. Based on minimum biofilm eradication 
concentration (MBEC)/minimum inhibitory concentration (MIC) ratios, the range of 
change in antibiotic susceptibility varied widely depending on the antibiotics (from 
≥ 3.1-fold to ≥ 475.0-fold). In conclusion, most P. aeruginosa isolates studied here 
had a genotype related to increase in SCCs. The efficiency of antibiotic therapy 
against P. aeruginosa-related bovine mastitis could be improved by analysing both the 
MBEC and the MIC of isolates. 
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Pseudomonas aeruginosa, one of the pathogens frequently isolated from 
cows affected with mastitis, exists in various environments and can infect the 
cow through the teat canal. The microorganism carries several virulence factors 
such as exotoxin A, exoenzyme and protease, which bring about inflammatory 
responses and cell death. The resultant increase in milk somatic cell counts 
(SCCs) and decrease in other milk components such as fat, lactose, casein and 
calcium has caused economic losses in the dairy farming industry (Park et al., 
2007). The bacterium also has intrinsic multidrug resistance that allows it to 
achieve further resistance. Moreover, most of the P. aeruginosa strains that have 
been isolated are strong biofilm producers that can reduce the efficacy of antibi-
otics and lead to chronic mastitis (Melchior et al., 2006). 
The pathogen uses a wide range of virulence factors, including proteins 
capable of inducing toxicity, which effectively damage tissues (Lyczak et al., 
2000). Some of these toxic effector proteins are injected into the cytosol of host 
cells through the type III secretion system (TTSS) and are involved in the disrup-
tion of epithelial surface and cell death. These TTSS proteins include cytotoxin 
(ExoU), ADP-ribosylating enzymes (ExoS and ExoT) and adenyl cyclase 
(ExoY). ExoU kills a variety of eukaryotic cells through its phospholipase activ-
ity. ExoT and ExoY are involved in adhesion, phagocytosis and systemic spread 
of the bacterial cells together with ExoS (Vance et al., 2005). ExoT and ExoY 
seem to play only minor roles in the pathogenesis, whereas ExoS and ExoU are 
known to determine specific patterns of pathogenesis (Engel and Balachandran, 
2009). For example, invasive strains, which break the epithelial barrier and dis-
seminate P. aeruginosa infection to other parts of tissues, usually possess the 
genes for ExoS, ExoT and ExoY, but lack the gene for ExoU. On the other hand, 
cytotoxic strains, which cause inflammation and tissue necrosis through their cy-
totoxic effect, typically possess the genes for ExoU, ExoT and ExoY, but lack 
the gene for ExoS (Fleiszig et al., 1997). These TTSS-expressing strains are ca-
pable of increasing the severity of disease (Roy-Burman et al., 2001) and have 
the ability to affect the SCCs and milk components by damaging mammary 
epithelial cells in the case of an intramammary infection. However, only a few 
studies have investigated the TTSS of P. aeruginosa isolated from bovine milk 
(Szmolka et al., 2012). 
Biofilm-forming ability is another important characteristic of P. aerugi-
nosa, which influences the pathophysiological pathway and antibiotic resistance 
of the bacterial cells, since the biofilm acts as a physiological barrier helping the 
bacteria to survive in a severe environment. In the mammary glands, biofilms fa-
cilitate the colonisation of the pathogens, their invasion into the epithelium and 
their evasion of the host’s immune defence mechanism, since a biofilm provides 
a dense and protected environment that allows the bacterial cells to co-operate 
and interact in various ways (Oliveira et al., 2006). In addition, biofilms increase 
antibiotic resistance through multiple mechanisms like disturbing antibiotic 
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penetration, general stress response and quorum-sensing. Under biofilm condi-
tions, P. aeruginosa becomes up to 1,000 times more resistant to antibiotics than 
under planktonic conditions (Mah and O’Toole, 2001). However, most previous 
studies on P. aeruginosa isolated from cows affected with bovine mastitis fo-
cused on the activities of antibiotics against planktonic bacteria only. 
In this study, TTSS-related genotypes of P. aeruginosa isolates obtained 
from the milk of cows affected with mastitis were screened and their influence 
on the SCCs and milk components (milk fat, milk protein and lactose) were stud-
ied. In addition, the antibiotic susceptibility profiles of P. aeruginosa of plank-
tonic and biofilm status  were also compared.  
 
 
Materials and methods 
Raw milk sampling, analysis and bacterial isolation 
From January 2006 to December 2011, a total of 35,625 raw milk samples 
were collected from nine provinces in Korea. Raw milk samples were collected 
from cows that showed swollen udder quarters or entirely swollen udders, ab-
normal milk secretion and loss of appetite. In addition, cows whose milk showed 
flakes or clots were also used as a source of raw milk. The milk was collected 
aseptically from individual udder quarters of the cows, as described previously 
(Moon et al., 2007). The SCCs of each milk sample, which indirectly show the 
quantity of dead epithelial cells and neutrophils in the milk, and the percentage 
of milk components, including milk fat, milk protein and lactose, were analysed 
using a somatic cell counter (Bently Somacount 300, USA). Milk samples show-
ing SCCs of over 500,000 cells/mL were suspected to be mastitic milk (De Haas 
et al., 2005). In total, 3,996 samples were suspected as mastitic milk, and bacteria 
were isolated from these samples. Briefly, a loop of milk (approximately 10 µl) 
was inoculated onto a cetrimide agar plate (Difco, USA) and incubated at 42 °C 
for 24 h. Putative P. aeruginosa isolates, acquired from the samples after using 
biochemical tests such as triple sugar iron (TSI) test, were confirmed by poly-
merase chain reaction (PCR) using the following P. aeruginosa-specific primers: 
PA-SS-F (5′-GGG GGA TCT TCG GAC CTC A-3′) and PA-SS-R (5′-TCC TTA 
GAG TGC CCA CCC G-3′) (Spilker et al., 2004). Overall, 462 P. aeruginosa 
isolates were confirmed and 122 isolates which were isolated alone without any 
other bacteria from raw milk samples were further examined. 
Detection of the TTSS-related toxin genes in P. aeruginosa 
The presence of four TTSS genes (exoS, T, Y and U) among the 122 P. 
aeruginosa isolates was examined by PCR using gene-specific primers, as de-
scribed previously (Ledbetter et al., 2009). The chromosomal DNA was ex-
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tracted with a DNeasy® blood and tissue kit (Qiagen Inc., USA) according to the 
manufacturer’s instructions for Gram-negative bacteria. The P. aeruginosa strain 
ATCC 27853 was used as a reference strain for validating the PCR results. 
Determination of minimum inhibitory concentration and minimum biofilm  
eradication concentration 
Minimum inhibitory concentration (MIC) of planktonic status P. aerugi-
nosa and minimum biofilm eradication concentration (MBEC) of biofilm status 
P. aeruginosa were compared using a Calgary Biofilm Device (Innovotech Inc., 
Canada) according to the manufacturer’s instructions. MIC was determined as per 
the guidelines established by the Clinical Laboratory Standards Institute (CLSI, 
2012) against the following 12 antibiotics: amikacin, aztreonam, cefoxitin, 
chloramphenicol, ciprofloxacin, colistin, erythromycin, gentamicin, kanamycin, 
meropenem, piperacillin and tetracycline. Escherichia coli ATCC 25922 and P. 
aeruginosa ATCC 27853 were used as quality control strains. 
Isolates showing resistance to at least one agent in three or more anti-
microbial categories were defined as multidrug-resistant (MDR) bacteria, and 
isolates showing resistance to at least one agent in all but two or fewer antim-
icrobial categories were classified into the extensive drug resistance (XDR) 
group. Isolates showing resistance to all agents in all antimicrobial categories 
were defined as pandrug-resistant (PDR) bacteria (Magiorakos et al., 2012). 
Statistical analysis 
Comparisons were made using one-way ANOVA and Student’s t-test. Dif-
ferences were judged significant at confidence levels of > 95% (P < 0.05). All 
data were analysed with SAS 9.3 for Windows (SAS Institute Inc, USA). 
 
 
Results 
Presence of the TTSS-related toxin genes among P. aeruginosa isolates  
from bovine mastitic milk 
Of the 122 P. aeruginosa isolates, 99.2% (121/122) possessed at least 1 of 
the 4 TTSS-related genes evaluated in this study (Table 1). One hundred P. 
aeruginosa isolates (82.7%) harboured exoU and/or exoS genes, including the 
non-cytotoxic/invasive strain (exoU–/exoS+, 69.4%), cytotoxic/non-invasive 
strain (exoU+/exoS–, 8.3%) and the cytotoxic/invasive strain (exoU+/exoS+, 
5.0%). The genes exoY and exoT were detected in 53 and 88 isolates (58.9 and 
97.8%) of invasive strains, respectively. 
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Table 1 
Distribution of the type III secretion system-related genotypes among Pseudomonas aeruginosa strains isolated from the milk of mastitis-affected 
dairy cows 
 exoU exoS exoY exoT No. of isolates Percentage (%)
Non-cytotoxic/Invasive strain (exoU–/exoS+) 
– 
– 
– 
+ 
+ 
+ 
+ 
– 
+ 
+ 
+ 
– 
46 
36 
2 
37.7 
29.5 
1.6 
Cytotoxic/Non-invasive strain (exoU+/exoS–) 
+ 
+ 
+ 
– 
– 
– 
– 
+ 
– 
+ 
+ 
– 
8 
1 
1 
6.6 
0.8 
0.8 
Cytotoxic/Invasive strain (exoU+/exoS+) + + 
+ 
+ 
+ 
– 
+ 
+ 
5 
1 
4.1 
0.8 
Non-cytotoxic/Non-invasive strain (exoU–/exoS–) 
– 
– 
– 
– 
– 
– 
– 
+ 
– 
+ 
+ 
– 
19 
2 
1 
15.6 
1.6 
0.8 
Total     122 100 
Table 2 
Milk component levels and somatic cell counts (SCCs) of milk samples from mastitis-affected cows 
Milk fat (%) Milk protein (%) Lactose (%) SCCs (× 103 cells/ml)  
Mean SE Mean SE Mean SE Mean SE 
Cytotoxic/Invasive strain (exoU+/exoS+) 3.4 0.8 3.3 0.1 4.5 0.2 2449.0 236.0 
Non-cytotoxic/Invasive strain (exoU–/exoS+) 4.0 0.1 3.3 0.1 4.5 0.0 1509.6 148.4 
Cytotoxic/Non-invasive strain (exoU+/exoS–) 4.3 0.4 3.2 0.2 4.4 0.2 1294.2 431.4 
Non-cytotoxic/Non-invasive strain (exoU–/exoS–) 3.4 0.1 3.2 0.1 4.6 0.1 784.1 66.6 
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Relation between TTSS-related genotypes  
and bovine mastitic raw milk components 
The SCCs and milk components (milk fat, milk protein and lactose) in 
mastitic raw milk are summarised in Table 2, according to the 4 TTSS-related 
genotypes of P. aeruginosa isolated from samples of mastitic raw milk. No sta-
tistically significant differences were observed in milk components with respect 
to the TTSS-related genotypes of isolates (P = 0.2, 0.7 and 0.6 for milk fat, milk 
protein and lactose, respectively). In terms of SCCs, significant differences were 
found among mastitic raw milk samples containing the cytotoxic/invasive strain, 
the non-cytotoxic/invasive strain and the non-cytotoxic/non-invasive strain (P < 
0.05). However, there was no statistically significant difference between mastitic 
raw milk samples containing the cytotoxic/non-invasive strain and the samples 
containing the non-cytotoxic/non-invasive strain (P = 0.3). Samples containing 
the cytotoxic/invasive strain showed a significantly higher SCCs than those con-
taining both cytotoxic/non-invasive and non-cytotoxic/invasive strains (P < 0.05; 
Fig. 1). 
 
Fig. 1. Somatic cell counts of raw milk samples of mastitis-affected cows sorted according to the 
type III secretion system-related genotypes of Pseudomonas aeruginosa. Asterisk (*) denotes  
significant difference 
Antibiotic susceptibility profile of planktonic and biofilm status P. aeruginosa 
The MIC of 122 isolates was measured and all isolates under planktonic 
cell status were found to be resistant to tetracycline and erythromycin (Fig. 2). 
Most of the planktonic status P. aeruginosa showed resistance or intermediate 
resistance to chloramphenicol (99.2% of resistance and 0.8% of intermediate re-
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sistance), cefoxitin (93.4% and 6.6%), aztreonam (86.9% and 11.5%), kanamycin 
(65.6% and 34.4%), piperacillin (63.9% and 0%), colistin (94.3% and 5.7%) and 
gentamicin (23.0% and 43.4%). Amikacin, meropenem and ciprofloxacin showed 
comparatively higher activity against planktonic status P. aeruginosa (77.9%, 
86.9% and 98.4% of susceptibility, respectively) than other antibiotics. The 
MBEC of biofilm status P. aeruginosa was measured, and the MBEC/MIC ratio 
was calculated for each isolate (Table 3). The MBEC values of isolates against 
all antibiotics were higher than the MIC values. Even gentamicin, amikacin, 
meropenem and ciprofloxacin, which showed a relatively higher activity against 
planktonic status P. aeruginosa, had a MBEC value higher than 200 μg/mL; 
therefore, their MBEC/MIC values were greater than 40 (≥ 68.1, ≥ 44.3, ≥ 475.0 
and ≥ 407.1, respectively). 
 
Fig. 2. Antibiotic resistance rates of the 122 bovine Pseudomonas aeruginosa isolates, based on the 
minimum inhibitory concentration (MIC) values measured by the broth dilution method.  
TET, Tetracycline; ERY, Erythromycin; CHL, Chloramphenicol; COL, Colistin; CFT, Cefoxitin; 
AZT, Aztreonam; KAN, Kanamycin; PIP, Piperacillin; GEN, Gentamicin; AMK, Amikacin;  
MEP, Meropenem; CIP, Ciprofloxacin 
 
A total of 96.7% (118/122) and 16.4% (20/122) of planktonic status P. 
aeruginosa cells could be defined as MDR and XDR, respectively. No PDR iso-
late was detected in this study. 
 
Discussion 
In the dairy farming industry, reducing the SCCs is still a serious issue to 
be considered in the production of high-quality milk, although the incidence of 
mastitis in dairy cattle has decreased because of steady efforts to control mastitis. 
Moreover, high prevalence of subclinical and chronic mastitis due to recurrent 
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infection has also been a persistent problem in the dairy farming industry (Hiller-
ton and Kliem, 2002). The bacterium P. aeruginosa plays a critical role in the in-
crease of SCCs and recurrent infection by causing cell death in the udder tissue 
and decreasing the efficiency of antibiotic therapy by forming biofilms (Melchior 
et al., 2006; Park et al., 2007). 
Table 3 
Minimum biofilm eradication concentration (MBEC)/minimum inhibitory concentration (MIC)  
ratios of 122 Pseudomonas aeruginosa isolates for 12 antibiotics 
MIC MBEC MBEC/MIC ratio* 
Antibiotics 
Mean SE Mean SE Mean SE 
CIP 0.5 0.0 ≥ 206.7 16.1 ≥ 407.1 31.8 
MEP ≥ 10.9 5.9 ≥ 410.2 16.4 ≥ 475.0 38.6 
GEN ≥ 23.8 7.2 ≥ 442.0 13.7 ≥ 68.1 4.3 
AMK ≥ 32.1 8.1 ≥ 460.5 11.4 ≥ 44.3 3.0 
COL 111.4 15.4 ≥ 471.3 10.6 ≥ 34.7 3.0 
KAN 158.2 13.5 ≥ 476.9 10.0 ≥ 11.9 1.4 
TET ≥ 177.6 16.8 ≥ 490.0 7.8 ≥ 6.7 0.5 
ERY ≥ 233.2 14.1 ≥ 497.3 6.5 ≥ 3.7 0.4 
CHL ≥ 242.0 15.6 ≥ 512.0 0.0 ≥ 4.0 0.4 
PIP ≥ 271.0 20.0 ≥ 507.8 3.0 ≥ 11.1 2.0 
AZT ≥ 357.0 20.1 ≥ 508.9 3.1 ≥ 7.6 1.1 
CFT ≥ 402.1 16.6 ≥ 509.9 2.1 ≥ 3.1 0.5 
*MBEC/MIC ratio is a numerical value obtained by dividing MBEC by MIC for each isolate. As 
the maximum antibiotic concentration in this study was 512 μg/mL, the same value was used in 
calculations with MIC or MBEC values higher than 512 μg/mL, and these values have been pre-
sented with the inequality sign. CIP, Ciprofloxacin; MEP, Meropenem; GEN, Gentamicin; AMK, 
Amikacin; COL, Colistin; KAN, Kanamycin; TET, Tetracycline; ERY, Erythromycin; CHL, 
Chloramphenicol; PIP, Piperacillin; AZT, Aztreonam; CFT, Cefoxitin 
 
A total of 99.2% of P. aeruginosa isolates in Korea have at least 1 of 4 
TTSS-related genes, which is in harmony with earlier findings for human, envi-
ronmental and bovine isolates of P. aeruginosa (Wiehlmann et al., 2007; Se-
lezska et al., 2012; Szmolka et al., 2012). Of the 122 P. aeruginosa isolates, 
68.8% of isolates were non-cytotoxic/invasive strain (exoU–/exoS+), while only 
8.2% of isolates were cytotoxic/non-invasive strain (exoU+/exoS–). Interest-
ingly, 6 isolates possessing both exoU and exoS were detected, which is a notable 
finding since exoU and exoS appear to be mutually exclusive in different P. 
aeruginosa populations in human and environmental isolates (Wiehlmann et al., 
2007; Selezska et al., 2012). 
Since both cytotoxic and invasive strains are known to be able to cause in-
flammation and necrosis of infected epithelial cells, although severe inflamma-
tion and necrosis are associated with cytotoxic strains (Fleiszig et al., 1997), 
 PSEUDOMONAS AERUGINOSA FROM BOVINE MASTITIC MILK 9 
Acta Veterinaria Hungarica 62, 2014 
those were expected to cause an increase in SCCs in the case of an intramam-
mary infection. Mastitic raw milk containing the cytotoxic/invasive strain, cyto-
toxic/non-invasive strain and non-cytotoxic/invasive strain did not show lower 
levels of milk components (milk fat, milk protein and lactose) than those contain-
ing the non-cytotoxic/non-invasive strain. In contrast, the SCCs was higher in 
mastitic raw milk containing the cytotoxic/invasive strain and the non-
cytotoxic/invasive strain than in the milk containing the non-cytotoxic/non-
invasive stain. It is suggested that the TTSS might lead to an increase in SCCs by 
causing inflammatory reactions and recruiting inflammatory cells rather than by 
damaging the mammary epithelial cells. Cytotoxic/invasive strains possessing 
both exoS and exoU had a significantly higher effect on the increase in SCCs 
than the cytotoxic/non-invasive strains with exoU alone, and non-cytotoxic/ 
invasive strains with exoS showed a higher increase in SCCs than did the cyto-
toxic/non-invasive strains possessing exoU. It is also suggested that exoS might 
be involved in inflammatory reactions and necrosis to a greater extent than ex-
pected. Therefore, most of the P. aeruginosa isolates in this study, which had ei-
ther exoS or exoU, should be considered as pathogenic for dairy cows. 
Approximately 40% of mastitis cases develop into subclinical and chronic 
mastitis after failed therapy (Hillerton and Kliem, 2002). Most recurrent infec-
tions are often attributable to biofilm formation by bacteria. Since a biofilm ma-
trix protects the bacterial cells from antibiotics and immune cells, bacteria in the 
biofilm can survive the action of antibiotics and result in recurrent infection. 
In this study, more than 60% of planktonic status P. aeruginosa showed 
resistance to tetracycline, erythromycin, chloramphenicol, colistin, cefoxitin, az-
treonam, kanamycin, piperacillin, gentamicin and amikacin which were approved for 
treatment of bovine mastitis and feed additives. In contrast, resistance rates for 
meropenem and ciprofloxacin, which were not permitted for veterinary use, were 
lower than 5%. Since prescription from a veterinarian for antibiotics had not been 
obligatory until August 2013, more than 50% of antibiotics consumed in farm 
animals have been used indiscriminately by non-professional persons. In addition, 
about 40% of antibiotics had been used as feed additives before such use was re-
stricted (in July 2011). The amount of antibiotics used in farm animals was about 
1,500 tons per year in Korea, which is 2 to 10 times higher than that of overseas 
countries considering the scale of livestock industry in Korea (Jung et al., 2008). 
This causal relationship between antibiotic usage and antibiotic resistance 
was also reflected in the resistance rate for colistin, and the resistance rate con-
firmed in this study was higher than that found in a previous study (Sumathi et 
al., 2008). Like other antibiotics, colistin had been widely used in feed additives 
in Korea and the amount of polypeptides used in animals as feed additive had in-
creased steadily (from 34 tons in 2001 to 46 tons in 2007) until the restriction. 
High colistin resistance was already reported not only in P. aeruginosa from bo-
vine but also in Acinetobacter spp. from humans, which is worth noting because 
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colistin has been considered as a limited antibiotic option for the treatment of P. 
aeruginosa and Acinetobacter spp. infections and is used as a ‘last resort’ in hu-
man medicine (Ko et al., 2007; Park et al., 2009). Given the importance of 
colistin and other antibiotics used as a limited antibiotic option, more careful us-
age of these antibiotics is essential. 
After biofilm formation, biofilm status P. aeruginosa resisted antibiotics 
more strongly and resulted in notable changes in antibiotic susceptibility pat-
terns. The MBEC of P. aeruginosa isolates differed from the MIC against all 
kinds of antibiotics tested, and the antibiotics applied at MIC failed to kill 
biofilm status P. aeruginosa. Even gentamicin, amikacin, meropenem and cipro-
floxacin, which were effective against most of the planktonic status isolates in 
this study, failed to eradicate biofilm status isolates at the MIC. In the case of 
meropenem and ciprofloxacin, this tendency was remarkably evident from the 
particularly high MBEC/MIC ratio of the antibiotics. MBEC/MIC values for 
chloramphenicol, tetracycline and cefoxitin were relatively lower than those for 
other antibiotics. However, this result might be caused by the high MIC values 
rather than the low MBEC values, owing to the intrinsic resistance of P. aerugi-
nosa to chloramphenicol, tetracycline and cefoxitin. These data suggested that 
antibiotics that are effective against planktonic status P. aeruginosa could fail to 
eradicate biofilm status P. aeruginosa isolates, and biofilm formation could be a 
critical factor resulting in the failure of antibiotic therapy due to the intrinsic re-
sistance mechanisms of bacteria. The findings also suggest that MBEC as well as 
MIC should be reflected in the treatment process and that the MBEC/MIC ratio 
could help exclude antibiotics ineffective against biofilm status P. aeruginosa. In 
addition, the MBEC of other biofilm-forming bacteria associated with mastitis, 
such as Staphylococcus aureus, may help to increase treatment efficiency. 
Our results indicate that most of the P. aeruginosa isolates originating 
from the raw milk of mastitis-affected dairy cows in Korea had a genotype that 
may be related to an increase in the SCCs. The efficiency of antibiotic therapy 
against bovine mastitis involving P. aeruginosa could be improved if data per-
taining to MBEC values as well as MIC test results were applied together during 
treatment. 
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